Literature DB >> 22411688

Spatial patterns of the tau pathology in progressive supranuclear palsy.

Richard A Armstrong1, Nigel J Cairns.   

Abstract

Progressive supranuclear palsy (PSP) is characterized neuropathologically by neuronal loss, gliosis, and the presence of tau-immunoreactive neuronal and glial cell inclusions affecting subcortical and some cortical regions. The objectives of this study were to determine (1) the spatial patterns of the tau-immunoreactive pathology, viz., neurofibrillary tangles (NFT), oligodendroglial inclusions (GI), tufted astrocytes (TA), and Alzheimer's disease-type neuritic plaques (NP) in PSP and (2) to investigate the spatial correlations between the histological features. Post-mortem material of cortical and subcortical regions of eight PSP cases was studied. Spatial pattern analysis was applied to the NFT, GI, TA, NP, abnormally enlarged neurons (EN), surviving neurons, and glial cells. NFT, GI, and TA were distributed either at random or in regularly distributed clusters. The EN and NP were mainly randomly distributed. Clustering of NFT and EN was more frequent in the cortex and subcortical regions, respectively. Variations in NFT density were not spatially correlated with the densities of either GI or TA, but were positively correlated with the densities of EN and surviving neurons in some regions. (1) NFT were the most widespread tau-immunoreactive pathology in PSP being distributed randomly in subcortical regions and in regular clusters in cortical regions, (2) GI and TA were more localized and exhibited a regular pattern of clustering in subcortical regions, and (3) neuronal and glial cell pathologies were not spatially correlated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411688     DOI: 10.1007/s10072-012-1006-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  41 in total

1.  Neuronal expression of alphaB crystallin in cerebral infarction.

Authors:  Masayuki Minami; Tomohiko Mizutani; Ryuta Kawanishi; Yoshio Suzuki; Hiroshi Mori
Journal:  Acta Neuropathol       Date:  2003-02-26       Impact factor: 17.088

2.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

3.  Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.

Authors:  N J Cordato; A J Duggins; G M Halliday; J G L Morris; C Pantelis
Journal:  Brain       Date:  2005-04-20       Impact factor: 13.501

4.  The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advanced Alzheimer's disease.

Authors:  Petri Mattila; Takashi Togo; Dennis W Dickson
Journal:  Neurosci Lett       Date:  2002-03-01       Impact factor: 3.046

5.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome.

Authors:  I Tellez-Nagel; H M Wiśniewski
Journal:  Arch Neurol       Date:  1973-11

Review 6.  The neuropathology of progressive supranuclear palsy.

Authors:  P L Lantos
Journal:  J Neural Transm Suppl       Date:  1994

Review 7.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

8.  Expression of apolipoprotein E in ballooned neurons-comparative immunohistochemical study on neurodegenerative disorders and infarction.

Authors:  Kazuko Aoki; Toshiki Uchihara; Ayako Nakamura; Takashi Komori; Nobutaka Arai; Toshio Mizutani
Journal:  Acta Neuropathol       Date:  2003-07-24       Impact factor: 17.088

9.  Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue.

Authors:  T Yamada; P L McGeer; E G McGeer
Journal:  Neurosci Lett       Date:  1992-01-20       Impact factor: 3.046

10.  Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

Authors:  I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1996-01       Impact factor: 3.685

View more
  10 in total

Review 1.  Imaging pathological tau in atypical parkinsonian disorders.

Authors:  Sarah Coakeley; Antonio P Strafella
Journal:  Curr Opin Neurol       Date:  2015-08       Impact factor: 5.710

Review 2.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

3.  Neuroimaging evidence of gray and white matter damage and clinical correlates in progressive supranuclear palsy.

Authors:  Maria Cristina Piattella; N Upadhyay; M Bologna; E Sbardella; F Tona; A Formica; N Petsas; A Berardelli; P Pantano
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

4.  Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes.

Authors:  Alberto J Espay; Kariem Ezzat; Andrea Sturchio
Journal:  Mov Disord Clin Pract       Date:  2021-08-31

5.  Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.

Authors:  Lukas da Cruz Carvalho Iohan; Jean-Charles Lambert; Marcos R Costa
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.752

Review 6.  The neurogenetics of atypical parkinsonian disorders.

Authors:  Brent L Fogel; Mary C Clark; Daniel H Geschwind
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

Review 7.  Imaging tau pathology in Parkinsonisms.

Authors:  Sarah Coakeley; Antonio P Strafella
Journal:  NPJ Parkinsons Dis       Date:  2017-06-29

8.  Saccades in progressive supranuclear palsy - maladapted, irregular, curved, and slow.

Authors:  Aasef G Shaikh; Stewart A Factor; Jorge Juncos
Journal:  Mov Disord Clin Pract       Date:  2017-08-11

9.  Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease.

Authors:  Axel Lipp; Radmila Trbojevic; Friedemann Paul; Andreas Fehlner; Sebastian Hirsch; Michael Scheel; Cornelia Noack; Jürgen Braun; Ingolf Sack
Journal:  Neuroimage Clin       Date:  2013-09-20       Impact factor: 4.881

Review 10.  Tau Pathology in Parkinson's Disease.

Authors:  Xue Zhang; Fei Gao; Dongdong Wang; Chao Li; Yi Fu; Wei He; Jianmin Zhang
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.